Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
2,892
+1,779
+160% +$901K 0.03% 212
2026
Q1
$552K Buy
1,113
+43
+4% +$20.3K 0.02% 295
2025
Q4
$456K Buy
1,070
+2
+0.2% +$857 0.01% 321
2025
Q3
$507K Sell
1,068
-6
-0.6% -$2.84K 0.01% 309
2025
Q2
$504K Buy
1,074
+67
+7% +$30.6K 0.01% 266
2025
Q1
$469K Buy
1,007
+91
+10% +$41K 0.01% 246
2024
Q4
$383K Buy
916
+40
+5% +$18.2K 0.01% 281
2024
Q3
$418K Sell
876
-3
-0.3% -$1.37K 0.01% 250
2024
Q2
$386K Buy
879
+56
+7% +$24.6K 0.01% 248
2024
Q1
$382K Sell
823
-162
-16% -$70.1K 0.01% 249
2023
Q4
$405K Buy
985
+324
+49% +$128K 0.01% 237
2023
Q3
$246K Buy
661
+9
+1% +$3.42K 0.01% 256
2023
Q2
$248K Sell
652
-18
-3% -$6.57K 0.01% 260
2023
Q1
$238K Buy
670
+13
+2% +$4.35K 0.01% 261
2022
Q4
$214K Buy
+657
New +$206K 0.01% 264

Other funds holding LIN

Grimes & Company's LIN Position: Q2 2026 in Review

Grimes & Company increased its Linde (LIN) stake by 160% in Q2 2026, buying an estimated $901K and bringing the position to 2,892 shares worth $1.5M. The position accounts for 0.03% of the portfolio, ranked #212.

Grimes & Company first reported a position in LIN in Q4 2022 and has held it in 15 quarters since. 720 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Grimes & Company held 2,892 shares of Linde worth $1.5M as of Q2 2026.
  • Grimes & Company bought 1,779 Linde shares in Q2 2026, an estimated $901K.
  • Linde made up 0.03% of Grimes & Company's portfolio in Q2 2026, its #212 holding.
  • Grimes & Company first reported a position in Linde in Q4 2022 and has held it in 15 quarters since.
  • 720 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.